[go: up one dir, main page]
More Web Proxy on the site http://driver.im/

PL1891088T3 - Sposób oczyszczania białka wiążącego IL-18 - Google Patents

Sposób oczyszczania białka wiążącego IL-18

Info

Publication number
PL1891088T3
PL1891088T3 PL06763598T PL06763598T PL1891088T3 PL 1891088 T3 PL1891088 T3 PL 1891088T3 PL 06763598 T PL06763598 T PL 06763598T PL 06763598 T PL06763598 T PL 06763598T PL 1891088 T3 PL1891088 T3 PL 1891088T3
Authority
PL
Poland
Prior art keywords
binding protein
purification
purified
fluid
production
Prior art date
Application number
PL06763598T
Other languages
English (en)
Inventor
Strat Claire Le
Frederic Meuwly
Pierre Wenger
Pascal Valax
Gianni Baer
Henri Kornmann
Original Assignee
Ares Trading Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Ares Trading Sa filed Critical Ares Trading Sa
Publication of PL1891088T3 publication Critical patent/PL1891088T3/pl

Links

Classifications

    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J20/00—Solid sorbent compositions or filter aid compositions; Sorbents for chromatography; Processes for preparing, regenerating or reactivating thereof
    • B01J20/281—Sorbents specially adapted for preparative, analytical or investigative chromatography
    • B01J20/286—Phases chemically bonded to a substrate, e.g. to silica or to polymers
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K1/00—General methods for the preparation of peptides, i.e. processes for the organic chemical preparation of peptides or proteins of any length
    • C07K1/14—Extraction; Separation; Purification
    • C07K1/16—Extraction; Separation; Purification by chromatography
    • C07K1/22—Affinity chromatography or related techniques based upon selective absorption processes
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01J—CHEMICAL OR PHYSICAL PROCESSES, e.g. CATALYSIS OR COLLOID CHEMISTRY; THEIR RELEVANT APPARATUS
    • B01J20/00—Solid sorbent compositions or filter aid compositions; Sorbents for chromatography; Processes for preparing, regenerating or reactivating thereof
    • B01J20/30—Processes for preparing, regenerating, or reactivating
    • B01J20/32—Impregnating or coating ; Solid sorbent compositions obtained from processes involving impregnating or coating
    • B01J20/3231—Impregnating or coating ; Solid sorbent compositions obtained from processes involving impregnating or coating characterised by the coating or impregnating layer
    • B01J20/3242—Layers with a functional group, e.g. an affinity material, a ligand, a reactant or a complexing group
    • B01J20/3244—Non-macromolecular compounds
    • B01J20/3246—Non-macromolecular compounds having a well defined chemical structure
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K9/00—Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof
    • C07K9/006—Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof the peptide sequence being part of a ring structure
    • C07K9/008—Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof the peptide sequence being part of a ring structure directly attached to a hetero atom of the saccharide radical, e.g. actaplanin, avoparcin, ristomycin, vancomycin
    • B—PERFORMING OPERATIONS; TRANSPORTING
    • B01—PHYSICAL OR CHEMICAL PROCESSES OR APPARATUS IN GENERAL
    • B01D—SEPARATION
    • B01D15/00—Separating processes involving the treatment of liquids with solid sorbents; Apparatus therefor
    • B01D15/08—Selective adsorption, e.g. chromatography
    • B01D15/26—Selective adsorption, e.g. chromatography characterised by the separation mechanism
    • B01D15/38—Selective adsorption, e.g. chromatography characterised by the separation mechanism involving specific interaction not covered by one or more of groups B01D15/265 - B01D15/36
    • B01D15/3804—Affinity chromatography

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Analytical Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Biochemistry (AREA)
  • Biophysics (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Peptides Or Proteins (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Polysaccharides And Polysaccharide Derivatives (AREA)
PL06763598T 2005-06-10 2006-06-08 Sposób oczyszczania białka wiążącego IL-18 PL1891088T3 (pl)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
EP05105124 2005-06-10
US69041405P 2005-06-14 2005-06-14
PCT/EP2006/063029 WO2006131550A1 (en) 2005-06-10 2006-06-08 Process for the purification of il-18 binding protein
EP06763598A EP1891088B1 (en) 2005-06-10 2006-06-08 Process for the purification of il-18 binding protein

Publications (1)

Publication Number Publication Date
PL1891088T3 true PL1891088T3 (pl) 2012-03-30

Family

ID=34940147

Family Applications (1)

Application Number Title Priority Date Filing Date
PL06763598T PL1891088T3 (pl) 2005-06-10 2006-06-08 Sposób oczyszczania białka wiążącego IL-18

Country Status (17)

Country Link
US (1) US8217152B2 (pl)
EP (1) EP1891088B1 (pl)
JP (1) JP5091127B2 (pl)
AT (1) ATE529433T1 (pl)
AU (1) AU2006256763B2 (pl)
CA (1) CA2610804C (pl)
CY (1) CY1112312T1 (pl)
DK (1) DK1891088T3 (pl)
ES (1) ES2375831T3 (pl)
HR (1) HRP20110948T1 (pl)
IL (1) IL187935A (pl)
NO (1) NO340957B1 (pl)
PL (1) PL1891088T3 (pl)
PT (1) PT1891088E (pl)
RS (1) RS52273B (pl)
SI (1) SI1891088T1 (pl)
WO (1) WO2006131550A1 (pl)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2004081167A2 (en) * 2003-03-11 2004-09-23 Applied Research Systems Ars Holding N.V. Expression vectors comprising the mcmv ie2 promoter
US20080076708A1 (en) * 2003-05-13 2008-03-27 Valter Altarocca Active Variants of the Il-18 Binding Protein and Medical Uses Thereof
AU2004284243B2 (en) 2003-10-21 2010-11-04 Merck Serono Sa Minimal DNA sequence acting as a chromatin insulator and its use in protein expression
CA2544146C (en) * 2003-11-05 2012-10-02 Ares Trading S.A. Process for the purification of il-18 binding protein
PT1720979E (pt) 2004-03-01 2007-10-25 Ares Trading Sa Utilização de um meio de cultura de células sem soro para a produção de il-18bp em células de mamífero
WO2006003134A1 (en) 2004-06-29 2006-01-12 Ares Trading S.A. Process for the purification of il-18 binding protein
GB0416699D0 (en) 2004-07-27 2004-09-01 Prometic Biosciences Ltd Prion protein ligands and methods of use
DK1885753T3 (da) 2005-06-03 2011-10-03 Ares Trading Sa Fremstilling af rekombinant II-18-proteiner
WO2006131768A2 (en) * 2005-06-10 2006-12-14 Prometic Biosciences Limited Triazines as protein binding ligands
US9920110B2 (en) * 2011-03-09 2018-03-20 Cell Signaling Technology, Inc. Methods and reagents for creating monoclonal antibodies

Family Cites Families (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4737462A (en) 1982-10-19 1988-04-12 Cetus Corporation Structural genes, plasmids and transformed cells for producing cysteine depleted muteins of interferon-β
US4588585A (en) 1982-10-19 1986-05-13 Cetus Corporation Human recombinant cysteine depleted interferon-β muteins
US4959314A (en) 1984-11-09 1990-09-25 Cetus Corporation Cysteine-depleted muteins of biologically active proteins
US5116943A (en) 1985-01-18 1992-05-26 Cetus Corporation Oxidation-resistant muteins of Il-2 and other protein
US5017691A (en) 1986-07-03 1991-05-21 Schering Corporation Mammalian interleukin-4
US4879111A (en) 1986-04-17 1989-11-07 Cetus Corporation Treatment of infections with lymphokines
US4965195A (en) 1987-10-26 1990-10-23 Immunex Corp. Interleukin-7
US4904584A (en) 1987-12-23 1990-02-27 Genetics Institute, Inc. Site-specific homogeneous modification of polypeptides
DE3902948A1 (de) * 1989-02-01 1990-08-09 Telefunken Fernseh & Rundfunk Verfahren zur uebertragung eines signals
GEP20002142B (en) 1991-01-18 2000-06-25 Amgen Inc Method for Treatment and Prevention of TNF Mediated Diseases
US6117996A (en) * 1995-09-20 2000-09-12 Novo Nordisk A/S Triazine based ligands and use thereof
IL121860A0 (en) * 1997-08-14 1998-02-22 Yeda Res & Dev Interleukin-18 binding proteins their preparation and use
US7220717B2 (en) * 1997-08-14 2007-05-22 Yeda Research And Development Company Ltd. Interleukin-18 binding proteins, their preparation and use
GB9910807D0 (en) * 1999-05-10 1999-07-07 Prometic Biosciences Limited Novel detoxification agents and their use
DE60040225D1 (en) 1999-07-13 2008-10-23 Bolder Biotechnology Inc Erythropoietin immunglobulin fusionsproteine
IL131047A0 (en) 1999-07-22 2001-01-28 Yeda Res & Dev Use of il-18 inhibitors
CN1322897C (zh) 2000-02-21 2007-06-27 应用研究系统Ars股份公司 Il－18抑制剂的应用
ATE395075T1 (de) 2000-05-05 2008-05-15 Serono Lab Verwendung von il-18 inhibitoren zur behandlung und/oder prävention von atherosklerose
ME00549B (me) 2001-01-29 2011-10-10 Serono Lab Upotreba inhibitora il-18 za liječenje i/ili prevenciju srčanih oboljenja
ATE315647T1 (de) 2001-03-08 2006-02-15 Ares Trading Sa Interleukin -18 mutantenproteine, deren herstellung und verwendung
ES2334773T3 (es) 2001-05-16 2010-03-16 Yeda Research And Development Co. Ltd. Uso de inhibidores de il-18 para el tratamiento o prevencion de la sepsis.
CA2445664C (en) 2001-05-25 2012-03-06 Ares Trading S.A. Use of il-18 inhibitors for treating or preventing cns injuries
UA78516C2 (en) 2001-08-10 2007-04-10 Applied Research Systems Use of inhibitors of il-18 for treatment and/or prevention of hypersensitivity disorders, and in particular of delayed-type hypersensitivity
PL207303B1 (pl) 2002-03-22 2010-11-30 Inst Nat Sante Rech Med Zastosowanie inhibitora IL-18 do leczenia i/lub zapobiegania chorobom naczyń obwodowych i zastosowanie wektorów ekspresyjnych
WO2004081167A2 (en) 2003-03-11 2004-09-23 Applied Research Systems Ars Holding N.V. Expression vectors comprising the mcmv ie2 promoter
US20080076708A1 (en) 2003-05-13 2008-03-27 Valter Altarocca Active Variants of the Il-18 Binding Protein and Medical Uses Thereof
AU2004284243B2 (en) 2003-10-21 2010-11-04 Merck Serono Sa Minimal DNA sequence acting as a chromatin insulator and its use in protein expression
CA2544146C (en) 2003-11-05 2012-10-02 Ares Trading S.A. Process for the purification of il-18 binding protein
PT1720979E (pt) 2004-03-01 2007-10-25 Ares Trading Sa Utilização de um meio de cultura de células sem soro para a produção de il-18bp em células de mamífero
WO2006003134A1 (en) 2004-06-29 2006-01-12 Ares Trading S.A. Process for the purification of il-18 binding protein
DK1885753T3 (da) 2005-06-03 2011-10-03 Ares Trading Sa Fremstilling af rekombinant II-18-proteiner
WO2006131768A2 (en) * 2005-06-10 2006-12-14 Prometic Biosciences Limited Triazines as protein binding ligands

Also Published As

Publication number Publication date
CA2610804A1 (en) 2006-12-14
JP2008542432A (ja) 2008-11-27
CY1112312T1 (el) 2015-12-09
PT1891088E (pt) 2011-12-19
EP1891088B1 (en) 2011-10-19
IL187935A (en) 2015-10-29
ATE529433T1 (de) 2011-11-15
NO340957B1 (no) 2017-07-31
NO20080131L (no) 2008-03-07
RS52273B (en) 2012-10-31
US8217152B2 (en) 2012-07-10
AU2006256763B2 (en) 2012-08-02
HRP20110948T1 (hr) 2012-01-31
EP1891088A1 (en) 2008-02-27
ES2375831T3 (es) 2012-03-06
IL187935A0 (en) 2008-03-20
SI1891088T1 (sl) 2012-02-29
DK1891088T3 (da) 2012-01-30
CA2610804C (en) 2013-11-19
JP5091127B2 (ja) 2012-12-05
AU2006256763A1 (en) 2006-12-14
US20080200658A1 (en) 2008-08-21
WO2006131550A1 (en) 2006-12-14

Similar Documents

Publication Publication Date Title
IL187935A0 (en) Process for the purification of il-18 binding protein
IL175431A0 (en) Purification of il-18 binding protein
IL179997A0 (en) Process for purification of il-18bp
WO2007081851A3 (en) Affinity chromatography matrices and methods of making and using the same
WO2008087184A3 (en) Process for the purification of fc-containing proteins
IL187838A0 (en) Production of il-18 binding protein
UA99263C2 (ru) СПОСОБ ОЧИСТКИ Fc-СЛИТОГО БЕЛКА
WO2007016635A3 (en) Process for the purification of coenzyme q10
PL2092064T3 (pl) Sposób oczyszczania RNA na skalę preparatywną za pomocą HPLC
DE602004016796D1 (de) Reinigungverfahren für Synthesegas
EP1568710A3 (en) Antibody purification method
TW200508201A (en) Novel process for the preparation of roflumilast
ZA200610740B (en) Process for fine purification of 1-butenic streams
MY157846A (en) Process for the purification of fc-containing proteins
DK1817342T3 (da) Fremgangsmåde til affinitetsrensning
GB0505419D0 (en) High affinity purification of protein complexes
ITMI20051085A1 (it) Metodo di purificazione del cefotetan
IL199752A0 (en) Purification of taci-fc
SG155231A1 (en) Process for synthesis of dialkoxyorganoboranes
EP2129461A4 (en) CLEANING OF IMMUNOGLOBULINS